{"transactions":[{"id":4382043,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":177761,"kind":"person","name":"DAVE KAUSHIK J","position":1,"cik":"0001522751","reported_name":"DAVE KAUSHIK J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Interim CFO"}}],"security":"Options to purchase common stock","published_at":"2017-03-16T22:18:18.000Z","date":"2017-03-14","kind":"grant","acquired":true,"shares":250000,"price":1.39,"value":347500.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the terms of the company's Amended and Restated 2013 Stock Plan, 2% of the options shall vest each month from the date of grant. In addition, 100,000 options are subject to cancellation based on the obtainment of certain milestones."}],"balance_after":250000,"derivative":{"exercise_price":1.39,"expiration_date":"2027-03-14","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001213900-17-002501","document":"f4031417dave_actinium.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390017002501/f4031417dave_actinium.xml","form_type":"4"}}]}